SUMMARY:
In recent years, interest has grown in the antimicrobial properties of certain natural and non-natural peptides. The strategy of inserting a covalent branch point in a peptide can improve its antimicrobial properties while retaining host biocompatibility. However, little is known regarding possible structural transitions as the peptide moves on the access path to the presumed target, the inner membrane. Establishing the nature of the interactions with the complex bacterial outer and inner membranes is important for effective peptide design. Structure/activity relationships of an amphiphilic, branched antimicrobial peptide (B2088) are examined using environment sensitive fluorescent probes, electron microscopy, molecular dynamics simulations and high resolution NMR in solution and in condensed states. The peptide is reconstituted in bacterial outer membrane lipopolysaccharide extract as well as in a variety of lipid media mimicking the inner membrane of Gram-negative pathogens. Progressive structure accretion is observed for the peptide in water, LPS and lipid environments.
Despite inducing rapid aggregation of bacteria-derived lipopolysaccharides, the peptide remains highly mobile in the aggregated lattice. At the inner membranes, the peptide undergoes further structural compaction mediated by interactions with negatively charged lipids, likely causing redistribution of membrane lipids, which in turn resulted in increased membrane permeability, and bacterial lysis. These findings suggest that peptides possessing both enhanced mobility in the bacterial outer membrane and spatial structure facilitating its interactions with the membrane-water interface may provide excellent structural motifs to develop new antimicrobials that can overcome antibiotic-resistant Gram-negative pathogens.
Naturally occurring antimicrobial peptides (AMPs) are found in virtually all living organisms and form a critical part of the innate immune system in mammals, providing protection against pathogen invasion (1, 2) . More than 1000 different antimicrobial peptides have been documented with activity against viruses, bacteria and fungi, prompting interest in using the structural principles of small cationic, amphiphilic molecules for improving and fine tuning target specificity and efficacy (3) (4) (5) (6) . Non-natural multivalent AMPs (branched antimicrobial peptides) have been designed by conjugating copies of a peptide monomer to scaffold molecules via naturally occurring intermolecular disulfide bridges or unnatural scaffold linkers (7) . Branched peptides have been shown to have considerable advantages over their monomeric forms, such as improved antimicrobial activity (8) , maintaining high efficacy under physiological (high-salt) conditions (9, 10) , enhanced bacterial surface binding affinity (11) , decreased susceptibility to proteolytic degradation (12, 13) , and low cytotoxocity (14, 15) . However, the quantitative structure-activity relationships (QSAR) and physiochemical properties of branched antimicrobial peptides are still poorly understood at the atomic level.
Several different models have been proposed to explain the mechanism by which antimicrobial peptides kill bacteria. These include the formation of bilayer-spanning pores by -helical peptides (16) (17) (18) (19) (20) (21) , an electrostatic charge-based mechanism of strand peptides (22, 23) , as well as newly proposed mechanisms like membrane phase transition (24) and specific targeting (25, 26) . Recently, an interfacial activity model has been defined as the "the ability of a molecule to bind to a membrane, partition into the membrane-water interface, and alter the packing and organization of the lipids" (1, 2) . The model predicts that a molecule capable of accumulating at bacterial membranes at a sufficiently high concentration might be an effective antimicrobial molecule. However, despite many years of intensive research, there is still no consensus on the mechanism of action or structure-function relationships that underlie the remarkable ability of antimicrobial peptides to kill pathogens with widely varying cell wall structures (27, 28) .
Recently we designed a series of short (10 amino acids) linear peptides with strong antimicrobial activity against Gram-negative bacteria (29) . Our previous structural studies showed that these peptides dimerize in the lipid phase or in aqueous solution in a cooperative manner at concentrations corresponding to their minimal inhibitory concentrations (MIC) (30) . A V2 monomer peptide, which had promising activity and was very amenable to large-scale production, was chosen as a functional motif to build a covalent dimer (V2 dimer) peptide. In early studies the dimer showed significantly decreased MIC levels against reference bacteria Pseudomonas aeruginosa ATCC 9027 (29) . Structure-activity relationships of the dimer peptide at an atomic level are presented in this work.
To maintain consistency in the peptide series nomenclature we identified V2 dimer peptide as B2088. Compared to a variety of its analogous peptides and the commonly used antibiotic gentamicin, B2088 showed outstanding antimicrobial activity (see Table 1 ). More strikingly, no resistance developed after 15 bacterial serial passages. Neither a cytotoxic effect nor hemolysis was found at a peptide concentration of 2mg/ml when tested against human conjunctival epithelial cells. Corneal wound healing in a rabbit model was not compromised. In an attempt to understand both the mechanism of action and the basis of cytotoxicity, structural studies were carried out using an array of biophysical methods, providing an action mechanism that extended the carpet model. Spatial structure/dynamics and mobility of the branched peptide in heterogeneous media including live bacteria, LPS, liposomes and mixed micelles were studied using environment sensitive fluorescent probes, electron microscopy, High Resolution Magic Angle Spinning (HR-MAS), solution NMR and molecular dynamics simulations.
EXPERIMENTAL PROCEDURES
Labeled peptide synthesis-B2088, its analogous variants, and V2 monomer peptide, were produced using solid phase peptide synthesis (SPPS) method. HPLC and ESI-MS were subsequently performed for peptide purification and identification (29) . The sequences were (RGRKVVRR) 2 KK for B2088, and RGRKVVRRKK for the monomer, respectively. The secondary chain of B2088 was formed through the Lys9 group on the primary chain. Underlined amino acids were 15 Bactericidal kinetics of B2088-Standard and gentamicin resistant strains of P. aeruginosa (ATCC 9027 and DR 4877/07) were grown separately on tryptic soy agar (TSA) plates at 35 0 C for 24 hrs. The colonies were then picked from the plate and resuspended in United States Pharmacopia (USP) phosphate buffer (pH 7.2). The suspension was adjusted to 10 6 /10 7 cfu/mL with various concentrations of B2088 (2.75 µM, 5.5 µM, 11 µM, 22 µM) in separate tubes and incubated at 35 0 C. Aliquots of 100 µL samples were withdrawn at 10, 20, 30 and 60 minutes intervals and plated on TSA agar plates after serial dilution using the same buffer. Simultaneously the bacteria in USP phosphate buffer without peptide addition were used as a control and plated in a similar fashion. After 48 hours all the plates were checked and the colonies were calculated to give the cfu/mL. Time kill curve was plotted with time against the logarithm of the viable count.
Resistant assay. An experiment was designed to stimulate resistance development, using a reference strain of Pseudomonas aeruginosa (ATCC 27853). Bacteria were removed from the original master stock (not more than four passages) obtained from the American Type Culture Collection (ATCC). The experiment was conducted in three different sets, each one for B2088, gentamicin and norfloxacin respectively. The test was initiated by growing the bacteria in the presence of various concentrations of B2088, gentamicin or norfloxacin that encompassed their MICs. After 20 hours of incubation at 35 0 C, the bacteria that showed growth in the highest concentration was re-passaged in a fresh dilution series of B2088 or other antibiotics. The process was repeated every 20 hours for up to 18 passages and the MICs were determined at every passage as specified earlier.
Cytotoxicity Assay. Cytotoxicity was determined by measuring the amount of ATP generated by viable cells in culture using the CellTiter-Glo luminescent cell viability assay (Promega,Madison, WI). B2088 and the monomer peptide were incubated with a human conjunctiva epithelial cell line (IOBA-NHC) as described previously (31, 32) . The luminescent signal was read by a micro-plate reader (Tecan GeniosPro, Tecan Asia, Singapore). Blank wells containing only medium were included in each assay, and the reading was subtracted from each sample and control well. Using the luminescence of the untreated wells as 100%, the cell viability was calculated as:
Each condition was assayed in triplicate, and the experiments were repeated three times.
Hemolysis assay. The hemolytic activity of B2088 was determined by the amount of hemoglobin that was released from rabbit erythrocytes. Fresh rabbit red blood cells (RBCs) were isolated from the whole blood of New Zealand white rabbits, by centrifugation at 3000 rpm for 10 min. RBCs were further washed with sterile PBS for 2 times and diluted to 8% (v/v) stock solution in sterile PBS. B2088 was dissolved in and mixed with RBCs to prepare the desired concentration of B2088 in RBCs (final v/v= 4%). The mixtures were added to 96-well plates and incubated at 37 o C for 60 min. After incubation, the mixtures were transferred into 1.5 mL eppendorf tubes and centrifuged at 3000 rpm for 3 min. The supernatant (100 µL) was transferred into a clean 96-well plate and the amount of haemoglobin released was determined by measuring the absorbance (abs) at 576nm with TECAN infinite 200 microplate reader. 2% Triton X-100 and PBS were used as positive and negative control respectively. Percent of hemolysis was calculated using: Fluorescence emission studies-Outer membrane permeabilization was studied using Nphenyl-1-naphthylamine (NPN) assay as reported by Loh et al (33) . P. aeruginosa ATCC 9027 cultured overnight was harvested (3000 rpm, 4 ºC). The pellet was washed twice using 5 mM HEPES buffer (pH 7.2) and resuspended in the same buffer to OD 600nm of 0.4. Bacteria were placed in a 10 mm stirred cuvette and NPN was added to a final concentration of 10 M. Appropriate concentrations of B2088 were added and the increase in fluorescence intensity was monitored on a Quanta Master fluorescence spectrophotometer (Photon Technology International, New Jersey, USA). The excitation and emission wavelengths were set at 350 and 410 nm with slit widths at 2 and 5 nm, respectively.
Live bacteria were used for the depolarization assay of transmembrane potential. Late log phase P. aeruginosa ATCC 9027 bacteria were harvested by centrifugation and washed twice with 5 mM HEPES buffer, subsequently resuspended in the same buffer (OD 600 = 0.4). The membrane sensitive fluorescence probe 3,3'-Dipropylthiadicarbocyanine Iodide, diSC 3 (5) , was added to the bacterial suspension to a concentration of 0.1 M and incubated at room temperature for 1 hour. The fluorescence emission spectrum was recorded by monitoring the changes in emission intensity at 670 nm (at an excitation wavelength of 622 nm) until no further changes were seen in the intensity values. Time-dependent changes in emission intensities at 670 nm were recorded after adding various concentrations of B2088.
Transmission electron microscopy studies-The effect of B2088 on the morphology of LPS was investigated by transmission electron microscopy. A suspension of LPS (extracted from Pseudomonas aeruginosa 10, purchased from Sigma, product no. L8643), 1 mg/mL, was incubated with B2088 (70 M) for 2.5 h. A 1 L aliquot of this solution was placed on formvarcoated copper grids, stained with 1% uranylacetate, dried and imaged by a JEOL 100 TEM machine. The same LPS suspension sample without B2088 treatment was used as a control.
NMR sample preparation-Lipopolysaccharide extracted from Pseudomonas aeruginosa was bought from Sigma (product no. L8643). LPS extract powder, 10 mg, was dissolved in 1 mL Milli-Q water, resulting in 10 mg/mL stock. The average molecular weight of LPS is 10 kDa, so the stock molar concentration was about 1 mM. Different LPS to peptide ratios were tested, ranging from 1:40 to 1:5. LPS to peptide molar ratio 1:20 was finally used to acquire NMR spectra. The final 100 L NMR sample (for HR-MAS probe) contained 47 L B2088 peptide stock and 47 L LPS stock, 2 L DSS as chemical shift reference and 5 L D 2 O. Sample peptide concentration was 10 mM, and the LPS concentration was 5 mg/mL. DPC (5.3 mg), together with 5.0 mg POPG (both purchased from Avanti Polar Lipids) was directly dissolved in 0.5 mL of 30 mM phosphate buffer. This resulted in 3:1 DPC-POPG membrane mimicking micelle solutions (DPC 30 mM, POPG 13 mM). The final 500 L NMR sample contained 1 mM labeled B2088 in DPC-POPG mixed micelles.
POPG, 10 mg, together with 28 mg POPE powder were dissolved in chloroform, dried with N 2 and dissolved in 500 L PBS buffer. After several cycles of freezing and thawing, a mixed liposome medium was prepared. Homogenous unilamellar liposomal vesicles were obtained by passing the liposome medium through a membrane (pore size 0.4 m diamater) for ten times. The NMR sample was prepared by mixing 7 L labeled B2088 peptide stock with 35 L liposome medium, topped up with D 2 O, DSS, and PBS to 70 L. The final sample contained 2 mM of peptide, 26 mM POPG and 78 mM POPE. Following the same method, an NMR sample with a low concentration of POPE-POPG mixed liposomes was prepared (4 mM POPG and 6 mM POPE).
NMR experiments-NMR experiments were performed using a Bruker Avance II 700 MHz spectrometer at 25 ºC for aqueous and micelle solutions in cryo-probe; and 30 ºC for LPS, liposome and bacterial medium in HR-MAS probe. Standard 500 L homogenous solution samples were prepared for the cryo-probe, and 70 L heterogeneous samples were prepared for the HR-MAS probe. Two-dimensional (2D) homo-nuclear TOCSY, NOESY, and ROESY experiments were conducted with mixing times of 70 N-relaxation were analyzed using ten 1 H-15 N HSQC spectra with various delays. For T 1 , the delay time varied from 0.05 to 2.55 s; and for T 2 , the delay time varied from 0.05 to 1 s.
Residue specific resonance assignment and assignment of NOESY cross-peaks were performed using CARA (www.nmr.ch). 3D structures of B2088 peptide in various media were reconstructed using CYANA 3.0 (34).
pH titration experiments were performed on the sample of B2088 in DPC-POPG mixed micelles, starting from pH 8.77. For each 0.5 pH unit from pH 8 to pH 1, 1D 1 H, 2D
15 N-and 13 C-HSQC spectra were acquired. Hydro-chloride (HCl, 1 M) was used as the titrant, and 16 titration points were obtained in total.
DOSY experiments were performed with B2088 and the monomer peptide in phosphate buffer, DPC micelles (30 mM), and DPC-POPG (DPC 30 mM and POPG 3 mM) mixed micelles (30) . The pulsed magnetic field gradient strength was calibrated using the 
(1) where D L and D F are the diffusion coefficients of lipid micelles and free peptides in solution, respectively.
Molecular dynamics (MD) simulationsCharge densities of B2088 and monomer peptide were calculated using methods presented previously (30) . B2088 and monomer peptide structures in DPC-POPG mixed micelles were used for the calculations.
To study the impact of B2088 on membrane structure, both atomic and coarse-grained simulations were performed. We first studied the interactions of B2088 with a model micelle (DPC/POPG=3:1) using atomic MD simulations. The peptide was modeled using the CHARMM27 force field (35) , the lipids were modeled using the CHARMM36 parameter set (36) , and the water molecules were described by the TIP3P water model (37) . The coordinates of the micelle were obtained from a 100 ns MD simulation of the selfassembly of DPC-POPG lipid mixtures. The peptide, B2088 was put close to the micelle and subjected to a 200 ns MD simulation. In addition, coarse-grained simulations were also performed to study the interaction of B2088 with model membranes. For this purpose, a model bacterial membrane consisting of 384 POPE and 128 POPG lipids was constructed. The Martini force field (38) was used to model both the peptide and the lipids. As B2088 is highly positively charged, it is expected that electrostatic interactions will play an important role in peptide-membrane interactions. Thus we used the polarizable water model recently developed by the Martini group because this water model has been shown to correctly describe longrange electrostatic interactions (39) . In both atomic and coarse-grained simulations, a cutoff distance of 1.2 nm was used for both the LennardJones (LJ) and real-space electrostatic interactions, and the particle-mesh Ewald algorithm was employed to calculate the long-range electrostatic interactions in reciprocal space. During the MD simulations, temperature and pressure were maintained at 300 K and 1 bar, respectively. In the case of coarse-grained simulations of the peptidemembrane system, semi-isotropic coupling was used to maintain the pressure.
RESULTS
Antimicrobial activities of B2088 and its analogous peptides. Linearized B2088 (linear V2 dimer), truncated B2088 (truncated V2 dimer), B2088 with modified neutral spacers (V3 dimer and L2 dimer) and modified C-termini (V2-1A dimer, V2-1D dimer and V2-1K-amide dimer), were designed and chemically synthesized. Antimicrobial activities of those peptides against Gram-negative bacteria strains were tested and compared with B2088 (Table 1) .
Besides V3 dimer and L2 dimer, B2088 showed lower MIC values than the rest of the peptides. Peptides with modified charge state (V2-1A-dimer and V2-1D-dimer) and amphiphilicity (truncated V2 dimer) showed increased MICs, indicating amino acid composition is important for antimicrobial activity as stated in the interfacial activity model. On the other hand, peptides with similar amino acid composition, but different 3D structure also show lowered antimicrobial activity, like linear V2 dimer. This suggests exploring peptide structure and peptide-lipid interactions at an atomic level was necessary for understanding structure-function relationship of this peptide series. V3 dimer and L2 dimer showed comparable activity to B2088. The amphiphilicity and chemical composition of those peptides are similar to B2088, suggesting that a similar antimicrobial mechanism could be expected. We selected B2088 for further study as a representative molecule which is also comparatively easy to produce.
In experiments tracking kinetics of antibacterial activity, B2088 displayed rapid killing ability against the reference P. aeruginosa ATCC 9027, reducing an inoculum by more than 6 log cfu/mL in less than 10 minutes at two times of the MIC value (Fig. 1A) . Even for the gentamicin-resistant strain P. aeruginosa DR4877/07, reduction of >10 5 organisms could be achieved using less than 10 M B2088 within 20 mins (supplementary material Fig.S2 ), suggesting a membrane targeted action is likely. Resistance of P. aeruginosa ATCC 27853 against B2088 was also tested (Fig 1B) . Over more than 17 bacterial passages, the MIC value of B2088 only rises about 4 times higher. Whereas for Gentamicin, bacteria developed 32 times MIC resistance and for norfloxacin, more than 64 times higher MIC concentration was needed to inhibit the bacteria growth. Both bacterial killing kinetics and resistance assay suggest the likelihood of a membrane targeting action by B2088.
Cytotoxicity of B2088 against mammalian cells. Human conjunctival epithelial cells were chosen for in vitro cytotoxicity assay (Fig 2A) . Even at peptide concentration of 200 g/mL (i.e., 88 M, 16-32 times higher than B2088 MIC values for various pathogens, B2088 was found safe (86% cell viability), indicating a high therapeutic index.
Hemolytic activity of B2088 was tested using rabbit red blood cells. Up to peptide concentrations of 2 mg/ml, no hemoglobin release was detected (Fig 2B) . Applying B2088 to the rabbit eye in vivo, no clinically detectable effect was seen on corneal wound healing in a rabbit model (supplementary Fig S3) .
Lipid Phase Partition of B2088 and monomer peptide. To characterize the affinity of B2088 and its monomeric precursors for the lipid phase, translational diffusion coefficients (D S ) for free peptides and peptide micelle complexes were measured using DOSY experiments (40) . Pure DPC and mixed DPC-POPG micelles were used to represent mammalian and bacterial cell membranes, respectively. Table 2 shows the molar fractions of peptides bound to micelles (F L ) calculated using the measured diffusion coefficients (41) . This parameter reflects the lipophilicity and affinity of the peptides for the lipid membranes. Partitioning in zwitterionic DPC micelles was only ~50% for all studied peptides, in contrast to the full localization into the same lipid phase doped with anionic POPG lipids. This observation was consistent with their high antimicrobial activity and low cytotoxicity.
B2088 interacts with bacterial outer and inner membranes. We investigated the interactions of B2088 with bacterial outer and inner membranes using membrane probes. NPN, a membrane impermeable dye, was used to determine if the peptide acted on the outer membrane of P. aeruginosa ATCC 9027. As an impermeable hydrophobic molecule with weak fluorescence in buffer, disruption of the outer membrane allowed the dye to partition toward the inner membrane with enhanced fluorescence (42, 43) . Thus, an increase in fluorescence intensity can be used to estimate permeation of the bacterial outer membrane. Figure 3A shows that the addition of B2088 to the intact bacteria leads to an abrupt increase in the NPN fluorescence intensity. At a concentration of 5.3±0.1 M, B2088 lead to a 50% increase (PC 50 ) in NPN fluorescence emission intensity. This concentration corresponded to the previously determined MIC values, implying a correlation between outer membrane disruption and bacterial killing.
We next examined the effect of B2088 on the bacterial inner membrane using the membranepotential sensitive fluorescent dye diSC 3 5. This dye is taken up by the bacteria and self-quenched as the dye concentrates in the cytoplasmic inner membrane. Any disturbance of the membrane potential gradient across the inner membrane will result in the release of the dye and increased fluorescence intensity (44, 45) . Figure 3B shows the peptide concentration-dependent fluorescence dequenching of diSC 3 5, upon addition of B2088 to intact bacterial cells. Below the MIC values, minimal change in the fluorescence intensity was observed. However, above the MIC value, upon addition of B2088, a significant increase in fluorescence signal was observed immediately followed by a plateau phase (Fig. 3B) . The maximum change in fluorescence intensity was reached in less than 10 minutes, under which conditions time-kill assays showed a 99% reduction in bacteria viability.
B2088 structure and dynamic studies with bacterial outer membrane LPS extract. Lipopolysaccharides are negatively charged molecules decorating the outer leaf of the outer membrane of Gram-negative bacteria. P. aeruginosa LPS extract was used to study peptide/bacterial outer membrane interactions. In a wide range of explored concentrations above the MIC values, addition of B2088 immediately caused turbidity in an otherwise clear and stable solution of LPS micelles. Under TEM, we observed the LPS assembly transformed from a ribbon-like structure into large polymorphous aggregates (Fig. 4) .
The 3D structural analysis of B2088 in polymorphous LPS was carried out using NMR. Residual dipole-dipole interactions and magnetic anisotropy of the heterogeneous LPS precipitated by B2088 resulted in broadened and featureless 1 H solution NMR spectra. However, the use of the High-Resolution Magic Angle Spinning (HR-MAS) technique in combination with residue-selective 15 N and 13 C labeling of B2088 enabled us to obtain the structure of B2088 in complex with LPS. Under these conditions, a [ 1 H, 15 N]-HSQC spectrum of selectively 13 C, 15 N-labeled B2088 showed four well resolved cross-peaks with chemical shifts displaced from those found in aqueous solution. A minor conformation of the peptide was also detectable in the spectrum (Fig.  6BII) . The observed resonances were assigned to particular residues using 2D NOESY, 3D HNCA, and 15 N-resolved NOESY experiments. The assignment was extended to well resolved 1 H resonances stemming from the unlabeled residues.
The observation of multiple proton-proton NOEs under HR-MAS as well as 13 C chemical shifts (Fig.  5AI ) allowed us to reconstruct the 3D structure of the peptide using the program CYANA 3.0 (Fig.  6AI) . Intra-molecular dynamics were assessed via 15 N T1, T2 (Supplementary Table S3 ) and HNOE (Fig. 5BI ) relaxation measurements for four backbone amide moieties and a side-chain moiety of Arg 3. Due to the absence of a detectable compact globular fold of B2088, no attempt towards model-free modeling of the intramolecular dynamics was made.
In polymorphous large LPS aggregates, B2088 adopted an extended conformation with spectroscopically indistinguishable primary and secondary chains. Val residues were significantly more dynamically restrained than flanking Arg and Lys residues. Arg side-chains showed the highest flexibility implying that the Arg guanidinium groups were not immobilized by electrostatic interactions with the oppositely charged LPS. Although no direct inter-chain NOEs were detected, it appeared likely that in water and LPS the peptide exhibited a compact structure mediated by hydrophobic interactions between Val sidechains resulting in restricted backbone dynamics at the central hydrophobic residues. The translational diffusion rates in water indicated that the hydrodynamic radius of B2088 might be in close correspondence to that found for the structurally compact dimer of the non-covalently linked monomer peptides (Supplementary Table S2 ) (30) . In addition, the translational diffusion rates of B2088 in water showed no concentration dependence indicating that B2088 did not further dimerize presumably due to the absence of surface exposed hydrophobic groups.
To test whether the aggregation of LPS was only due to the effect of electrostatic neutralization of LPS by counter-charged groups of the peptide, calcium chloride was used to induce LPS aggregation. The results showed that to induce the same degree of LPS precipitation, a 300-fold higher concentration of calcium chloride was needed. These findings emphasized the importance of the underlying 3D structure of the BAMP compared to linear AMPs and hydrated cations.
Although the translational diffusion rates of B2088 in aggregated LPS matrix was of considerable interest, the Z-gradient pulsed field strength available in the commercial HR-MAS probe was not sufficient for quantitative measurements of the rates. Nevertheless, data showed that while maintaining the high rotational diffusion rate, the translational diffusion of the peptide was significantly impeded in LPS but not quenched entirely. We propose that maintaining high mobility in heterogeneous condensed phase enables the peptide to penetrate through the LPSdecorated bacterial outer membrane and diffuse into the bacterial inner membrane, as was shown by environment sensitive fluorescent assays. Serving as bacterial membrane extensions, LPS molecules effectively enlarge the reactive surface of the bacteria in relationship to the volume; interacting with LPS through strong electrostatic attractions also helps B2088 to achieve effective high concentrations at the bacterial outer membrane.
B2088 structure and dynamic studies in bacterial inner membrane mimics. To explore conformational transitions and dynamics of the peptide in lipid phases, we used neutral and negatively charged micelles mimicking the lipid composition of mammalian cell membrane as well as bacterial inner membrane, respectively. The binding affinity of B2088 to mixed micelles was explored using DOSY experiments. The peptide showed only weak partitioning into the neutrally charged DPC micelles. Admixture of POPG (DPC:POPG = 3:1) increased the total negative charge of micelles causing full partitioning of the peptide into the lipid phase. This was accompanied by accretion of a compact 3D structure of the peptide shown in the HSQC spectrum (Fig. 6BIII ) and HNOE data (Fig. 5BIII) . Moreover, primary and secondary chains of B2088 manifested different structural associations as the degeneration of resonances stemming from those chains was abolished in the HSQC spectrum (Fig.  6BIII) . We determined the detailed 3D structure of B2088 in DPC/POPG micelles (Fig. 6AII ) using NOEs and 13 C  chemical shifts (Fig. 5AIII) . In this structure the primary backbone chain was folded back around the secondary chain with four Val residues occupying the core positions with NOE constrains from Arg'7 (secondary chain) to Val 5 and, Arg'8 to Arg 3 proving the spatial proximity between the two chains. Differential structural association between the two chains implied that the covalent branched linkage might provide a new structural quality surpassing just a means to facilitate chemical association.
Several studies have described a strong link between the cationic charge on a peptide and its antimicrobial activity (46) . In addition, the local charge distribution and density within the a peptide have been hypothesized to be important factors (47) . We had earlier developed a metric of the peptide charge density as the ratio of the total charge on the peptide and its volume (30) . Our findings suggested a strong correlation between charge density and antimicrobial activity. Thus, we compared the charge density of the monomer and B2088 based on their structures in DPC-POPG micelles (supplementary Fig. S5 ). Remarkably, B2088 in DPC-POPG micelles had a 30% greater charge density than the monomer, implying a direct connection between 3D structure and antimicrobial activity.
The nature of lipid/peptide interactions were explored by pH scanning experiments using NMR and MD simulations utilizing both atomic and coarse-grained membrane models (Fig. 7) . 1 (Fig. 7C) . We found that the intrinsic basic pKa of Arg guanidinium groups and acidic pKa of lipid protons near phosphate groups ( 1 H  ) were shifted towards each other in the peptide/micelle complex, suggesting electrostatic interactions or hydrogen bonding between these groups. Atomic simulations using peptides in DPC/POPG mixed micelles showed transient hydrogen-bonds between peptide Arg/Lys side chains and lipid phosphate groups. Arg manifested greater hydrogen bonding ability than Lys (Fig.  7BI) . This is probably due to the fact that the guanidinium group of Arg can form double hydrogen bonds with PO 4 groups, which is energetically more favorable than the hydrogen bond between Lys side-chain and lipids (48, 49) . Coarse-grained simulations using POPG doped bacterial membrane models showed that B2088 initially solvated in water, rapidly adsorbed onto the negatively charged membrane surface and remained at the membrane water interface (Fig.  7BII) . Moreover, B2088 showed clear preferential interactions with anionic POPG rather than zwitterionic DPC and POPE, leading to redistribution of membrane lipids and emergence of POPG-rich domains (Supplementary Figure S6) . These may decrease the membrane stability, eventually resulting in membrane depolarization that is observed in the fluorescent assays.
Retaining high rotational mobility of B2088 in lipids enabled the extension of structural studies of the peptide to POPE/POPG mixed liposomes. In accordance with other studies of AMPs in lipid vesicles (50), at concentrations above 0.1 mM B2088 caused immediate turbidity in an otherwise clear solution of mixed liposomes with POPE:POPG = 3:1 used to mimic bacterial anionic membranes. Due to the large size and complex morphology of the resulting magnetically anisotropic and inhomogeneous peptide/liposome solutions, HR-MAS NMR was employed in order to detect resolved NMR spectra. We found that at the stoichiometric ratio of B2088:POPE:POPG = 1:39:13, the peptide exhibits reduced rotational diffusion rates and intra-molecular dynamics comparable to that found in DPC/POPG micelles (Fig. 6CIII) . With an increase in the relative peptide concentration of B2088:POPE:POPG = 1:3:1, accelerated rotational diffusion of the peptide similar to that found in LPS accompanied by chemical shift changes in the [ 1 H, 15 N]-HSQC spectra was detected (Fig. 6CI) . Analysis of the spectra showed that at lower peptide concentrations two sets of cross-peaks stemming from predominantly membrane bound and membrane dissociated states of the peptide, respectively, could be detected. Only one set of coalescent resonances was observed at intermediate peptide concentrations (Fig 6CII) . This indicated the slow to intermediate (in chemical shift time scale) exchange of peptide bound to, and dissociated from, the lipid surface. At a ratio of B2088:POPE:POPG = 1:39:13 about 0.056 peptide molecules were bound to 1 nm 2 of the liposome surface (1 peptide to 32 lipids). This can be compared to ~105 peptide molecules per 1 nm 2 of the bacterial surface (82 peptides to 1 lipid) estimated from our standard bacterial sterilization experiment (see Supplementary). These numbers clearly indicate significantly lower affinity of B2088 to model liposomes in comparison to live bacteria, corroborating observations from other studies (2) .
DISCUSSION
In this study, we used peptide B2088 to observe antimicrobial peptide permeation through bacterial outer membrane LPS, while inducing LPS phase transition. This was followed by structural transition of the AMP upon interaction with the inner membrane, which resulted in membrane disruption leading to bacterial death. Interestingly, we noticed this peptide exhibit different binding affinities to bacterial inner and outer membranes. To explore its significance, binding affinities of AMPs towards bacteria cells and bacterial outer/inner membranes were assessed based on B2088 experimental data and compared with previous literature. In order to establish a comprehensive comparison, both the dissociation constant,K d , and the molecular stoichiometric ratio in the complex were analyzed, providing binding affinity data emphasizing both the "quality" (nature and strength) of binding at equilibrium and their relative quantities.
Estimations of the activities (effective concentrations) of antimicrobial peptides in typical bacterial susceptibility tests showed that AMPs have to accumulate with a tremendous excess of peptides per membrane lipid molecule in order to induce the bactericidal effect (51) . The majority of known potent antimicrobial peptides exhibit bactericidal activity at or above the micro-molar range of concentrations in common bacterial sterilization assays reaching a peptide-to-lipid ratio of 100:1 (51). In our assays of B2088 we estimate that an excess of more than 100 peptide molecules per 1 nm 2 of the bacterial surface (82 peptides to 1 lipid molecule) is needed for the efficient inhibition of bacterial growth followed by cell lysis. The maximum saturation concentrations of AMP on the bacterial membranes are determined by the molecular affinities of AMPs to the interaction surfaces. Those affinities can vary wildly from the absence of interactions in the pH neutral membranes of mammals to highly sticky surfaces presented by bacterial membranes enriched with negatively charged lipids, like phosphatidlyglycerol and cardiolipin. In typical membrane binding experiments, there are about 1000 AMPs bound to each large unilamellar vesicles (LUV), which in turn may contain around 100,000 lipids (52, 53) . When using giant unilamellar vesicles (GUV), a small number of GUVs are exposed to 1-10 M peptides (54, 55) . Even in the stoichiometric excess of AMPs in solution, the saturation (equilibrium) concentration of AMP on the surface does not exceed 1 AMP per 20 lipids (51). This is supported by our measurements of the equilibrium binding constants of B2088 to liposomes indicating an average of 0.056 peptide molecules bound for each 1 nm 2 of the liposomal surface (1 peptide to 32 lipids). Apparently, the surface of liposomes or vesicles can't provide sufficient affinity to accommodate the tremendous excess of AMPs required to disrupt membrane integrity, even in the presence of negatively charged lipids.
Our experiments suggest that interactions with LPS may provide an additional increase in the affinity of AMPs to the complex bacterial surfaces. The net compounding effect of several concurrent electrostatic-mediated weak interactions of AMPs with LPS and negatively charged lipid membranes is a significant increase in net binding affinities and concomitantly equilibrium concentrations of AMPs on the bacterial surfaces as is exemplified in combinatorial chemistry producing higheraffinity ligands from lower affinity molecular fragments (56) . Previously it was estimated that the dissociation constant of AMPs interacting with LPS was in the low micromolar range (57,58), similar to the affinity level found for the interactions between AMPs and bacterial membrane lipids (59) . However, significantly stronger binding of AMP to live bacteria complex interfaces, typically in the sub-micromolar range, are estimated from experiments tracing AMP movements in the presence of bacterial surfaces (60) . These smaller dissociation constants can usually be explained through higher stoichiometric binding ratios allowing more AMPs at their recipient surfaces. A combination of interactions with LPS resulting in approximately 3 AMPs per a molecule of LPS (61, 62) and inner membrane binding resulting in 1 AMP per 50 molecules of lipids (51) , might enhance binding of AMPs to the composite surfaces consisting of LPS and lipids delivering a remarkably high equilibrium excess of AMPs per bacterial lipid molecule typically found in bacteria susceptibility tests (100:1). Our experimental observations are in good agreement with these estimates, suggesting that a combination of interactions of B2088 with LPS (peptides-per-LPS ratio = 5:1) and the inner membrane mimics (peptides-per-lipids = 1:32), might provide significant enhancement of affinity to reach the stoichiometric ratios required for the bactericidal effect (Table 3) .
Remarkably, upon AMPs-LPS interaction, liquid expanded domains in the bacterial outer membrane were replaced by liquid condensed domain structures (63-66). In atomic force microscopy, transformation of LPS assembly from ribbon-like structures into large and densely packed multilamellar aggregates was seen upon addition of AMPs (67) . In our experiments the full absorption of B2088 into the LPS was detected. Interactions with B2088 caused an LPS phase transition from isotropic micelle solution to large insoluble aggregates. AMPs strongly attracted by LPS but locked into the polymorphous outer membrane showed no antimicrobial activity (63,68). B2088 retains its rotational molecular mobility, slowed down translational diffusion and 3D structure resembling that found in aqueous solution. The high molecular mobility of B2088 enabled it to permeate through the bacterial outer membrane and accumulate at the surface of the inner membrane at sufficient concentrations. Although LPS can increase total affinity of AMPs to bacterial surfaces, it is not clear how AMPs shall penetrate though oppositely charged medium without being locked. While "self-promoted" uptake via displacement of LPS binding divalent cations has been proposed (69, 70) , LPS phase transition seems critical for providing space to facilitate permeation of AMPs.
These observations support the interfacial activity model, which states that the antimicrobial activity of an antimicrobial peptide depends on "the ability of a molecule to bind to a membrane, partition into the membrane-water interface, and to alter the packing and organization of the lipids". Here we propose to extend this interfacial model to include more complex interfaces such as LPS/mixed lipids. We showed that B2088 retained translational and rotational mobility at a complex interface. This appears to directly correlate with the peptide's efficacy, helping to achieve significantly higher surface concentrations, which are required for its antimicrobial activity.
Sufficiently high concentrations of AMPs at the bacterial membrane promotes structural compaction in B2088, as observed by NMR, and may facilitate membrane remodeling. Upon association with the bacterial inner membrane, B2088 adopts a significantly more compact structure, facilitating full absorption into the membrane through extensive transient hydrogen bonds. Rather than a highly flexible structure in aqueous solution and LPS, the primary and secondary chains of B2088 show different chemical shifts and tight packing in the inner membrane mimicking micelles. In out MD simulation studies, such structural accretion helped to increase the strength and number of peptidemembrane lipids interactions, therefore resulting in redistribution of membrane lipids. Other studies reported similar concentration-dependent structural transitions associated with AMP activity (71) . Changes of peptide's orientations relative to the membrane were observed in both helix (72) (73) (74) and sheet (75) forming peptides. A two-state model of AMPs effect on bacterial lipid membranes was proposed (76) .
In fact all previous proposed models are calling for sufficiently high concentrations of AMPs on the surface in order to form supramolecular structures (as in "carpet model" or "barrel stave model") (77, 78) . In our own efforts of designing AMPs we found that covalent linkage of monomeric AMPs contributed to a significant increase of antimicrobial activities (7, 29) . Higher covalent oligomerization generally tends to increase affinities to lipid surfaces (79). However, large peptide oligomers are prone to be blocked in the LPS condensed phase, whereas a nonaggregated conformation is preferred for membrane-permeating activity (63). In our hands higher order AMPs also tend to be more cytotoxic, reflecting their increased interactions with mammalian membranes. B2088 retains its monomeric state in various media, which is in agreement with biophysical observations of other AMPs (80) (81) (82) . The trend in designing AMPs towards higher covalent order might be limited by increased cytotoxicity and can be counteracted by designing lower order AMPs, maintaining high mobility in LPS and providing higher concentrations at the lipid surfaces of bacteria. 2 The abbreviations used are: AMP, antimicrobial peptide; DPC, dodecylphosphocholine; POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; POPE, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine. (60) by assuming that the apparent concentration of AMP at which a qualitative change in AMP dynamics at the bacterial surface is observed. Figure 1 by guest on September 16, 2017 
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